Research and Markets: ISTA Pharmaceuticals, Inc.: Strategic Analysis Review of One of the Leading Manufacturers of Opthalmis Products

Business Wire, April 08, 2009

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/38982a/ista_pharmaceutica) has announced the addition of Global Markets Direct's new companyprofile "ISTA Pharmaceuticals, Inc. - Strategic Analysis Review" to their offering.

ISTA Pharmaceuticals, Inc. (ISTA) is a specialty pharmaceutical company engaged in developing, manufacturing, and marketing ophthalmic products. It provides ophthalmic products for the treatment of ocular pain, inflammation allergy, dry eye, and glaucoma. The major products of the company include Xibrom, Istalol and Vitrase. The company's Xibrom is used for treatment of ocular inflammation following cataract surgery. It is a topical non-steroidal anti-inflammatory formulation of bromfenac.

In-depth strategic and operational analysis of ISTA Pharmaceuticals, Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis and views on the company.

Scope

• The company's strengths and weaknesses and areas of development or decline are analyzed. Strategic and operational factors are considered.
• The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical company information - business structure and operations, company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.

Reasons to buy

• A quick "one-stop-shop" to understand the company.
• Enhance business/sales activities by understanding customers' businesses better.
• Get detailed information and strategic analysis on companies operating in your industry.
• Identify prospective partners and suppliers - with key data on their businesses and locations.
• Capitalize on competitors' weaknesses and target the market opportunities available to them.
• Scout for potential acquisition targets, with detailed insight into the companies' strategic and operational performance.

For more information visit http://www.researchandmarkets.com/research/38982a/ista_pharmaceutica